The U.S. Food and Drug Administration the equivalents to the Saudi Food and Drug Authority (SFDA) is warning consumers to immediately stop using Hydroxycut products by Iovate Health Sciences Inc., of Oakville, Ontario and distributed by Iovate Health Sciences USA Inc. of Blasdell, N.Y. Some Hydroxycut products are associated with a number of serious liver injuries. Iovate has agreed to recall Hydroxycut products from the market.

FDA provided healthcare professionals with updated information on the original March 2008 early communication and January 2009 follow-up communication about the ongoing safety review for the leukotriene inhibitors, montelukast, zafirlukast and zileuton. Neuropsychiatric events have been reported in some patients taking montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo and Zyflo CR). FDA has requested that manufacturers include a precaution in the drug prescribing information (drug labeling).

FDA notified healthcare professionals of an update to a previous alert that addresses the interaction of ceftriaxone with calcium-containing products, based on previously reported fatal cases in neonates. At the request of FDA, the manufacturer of ceftriaxone (Roche) conducted two in vitro studies to assess the potential for precipitation of ceftriaxone-calcium when ceftriaxone and calcium-containing products are mixed in vials and in infusion lines.

The U.S. Food and Drug Administration, the American counterpart to the Saudi Food and Drug Authority (SFDA), has required the manufacturers of the smoking cessation aids varenicline (Chantix) and bupropion (Zyban and generics) to add new Boxed Warnings and develop patient Medication Guides highlighting the risk of serious neuropsychiatric symptoms in patients using these products. These symptoms include changes in behavior, hostility, agitation, depressed mood, suicidal thoughts and behavior, and attempted suicide.

FDA notified both healthcare professionals and their patients about new safety information concerning products marketed for body building and increasing muscle mass, frequently marketed as alternatives to anabolic steroids for increasing muscle mass and strength and sold both online and in retail stores. These products are promoted to athletes to improve sports performance and to aid in recovery from training and sporting events.

The U.S. Food and Drug Administration today announced that the agency issued warning letters to eight companies marketing unlawful over-the-counter (OTC) topical drug products containing the pain reliever ibuprofen.

ضمن برنامج قطاع الدواء في الهيئة العامة للغذاء والدواء لمتابعة وتحليل المستحضرات والخلطات العشبية, وبناءا على ما توفر لدى القطاع عن وجود مستحضر باسم جلوكولايف ( Gluco Life ) مصدره كندا في السوق المحلي تم إخضاع المستحضر للتحليل المخبري حيث يحمل ادعاء طبي لعلاج داء السكري.

إشارة إلى المعلومات الواردة للهيئة العامة للغذاء والدواء عن قيام شركة ماكنيل للمنتجات الطبية بسحب بعض تشغيلات مستحضرات تيلينول ( Tylenol )، والمنتج من قبل شركة "جونسون أن جونسون" الأمريكية من أسواق الإمارات العربية المتحدة والولايات المتحدة الأمريكية.

أعلنت الهيئة العامة للغذاء والدواء عن إلغاء تسجيل مستحضر ( Sibutramine ) ، حيث أشار تقرير صادر من قبل وكالة الأدوية الأوروبية ( (EMEA بتعليق ترخيص مستحضر ( (Sibutramine وذلك استناداً إلي الدراسة التي أجريت على المستحضر وتبين منها أن المستحضر يمثل خطراً على الصحة وأن الأعراض الجانبية الخطيرة التي تظهر مع استخدام المستحضر والمتمثلة في ارتفاع احتمالية الإصابة بأمراض القلب والشرايين لا تتناسب مع الفائدة المرجوة .

The European Medicines Agency (EMEA) has now issued a public statement on a possible interaction between clopidogrel (Plavix) and proton-pump inhibitors (PPIs) and has recommended that the product information for all clopidogrel-containing medicines be amended to discourage concomitant use of PPIs unless absolutely necessary." The UK drug regulator, called the "Medicines and Healthcare Products Regulatory Agency (MHRA), has also issued advice to GPs that concomitant use of a PPI with clopidogrel is not recommended unless considered essential, urging a review of the prescribing